KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Retained Earnings (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Retained Earnings for 18 consecutive years, with $36.4 billion as the latest value for Q1 2026.

  • For Q1 2026, Retained Earnings rose 12.47% year-over-year to $36.4 billion; the TTM value through Mar 2026 reached $36.4 billion, up 12.47%, while the annual FY2025 figure was $77.5 million, 99.76% down from the prior year.
  • Retained Earnings hit $36.4 billion in Q1 2026 for Regeneron Pharmaceuticals, up from $77.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $36.4 billion in Q1 2026 and bottomed at -$275.1 million in Q3 2022.
  • Average Retained Earnings over 5 years is $16.0 billion, with a median of $23.3 billion recorded in 2022.
  • On a YoY basis, Retained Earnings climbed as much as 89056.87% in 2022 and fell as far as 101.64% in 2022.
  • Regeneron Pharmaceuticals' Retained Earnings stood at $23.3 billion in 2022, then rose by 16.96% to $27.3 billion in 2023, then rose by 16.19% to $31.7 billion in 2024, then tumbled by 99.76% to $77.5 million in 2025, then surged by 46898.45% to $36.4 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $36.4 billion, $77.5 million, and $35.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.